[go: up one dir, main page]

AU3860797A - Pharmaceutical formulations for oral administration - Google Patents

Pharmaceutical formulations for oral administration

Info

Publication number
AU3860797A
AU3860797A AU38607/97A AU3860797A AU3860797A AU 3860797 A AU3860797 A AU 3860797A AU 38607/97 A AU38607/97 A AU 38607/97A AU 3860797 A AU3860797 A AU 3860797A AU 3860797 A AU3860797 A AU 3860797A
Authority
AU
Australia
Prior art keywords
oral administration
pharmaceutical formulations
formulations
pharmaceutical
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38607/97A
Inventor
Owen Ignatius Corrigan
Rachel Helena Gubbins
Caitriona Mary O'Driscoll
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ANTRIN RESEARCH Ltd
Original Assignee
ANTRIN RESEARCH Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ANTRIN RESEARCH Ltd filed Critical ANTRIN RESEARCH Ltd
Publication of AU3860797A publication Critical patent/AU3860797A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AU38607/97A 1997-07-16 1997-07-16 Pharmaceutical formulations for oral administration Abandoned AU3860797A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IE1997/000049 WO1999003451A1 (en) 1997-07-16 1997-07-16 Pharmaceutical formulations for oral administration

Publications (1)

Publication Number Publication Date
AU3860797A true AU3860797A (en) 1999-02-10

Family

ID=11042506

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38607/97A Abandoned AU3860797A (en) 1997-07-16 1997-07-16 Pharmaceutical formulations for oral administration

Country Status (2)

Country Link
AU (1) AU3860797A (en)
WO (1) WO1999003451A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01007895A (en) 1999-02-03 2003-07-21 Biosante Pharmaceuticals Inc Therapeutic calcium phosphate particles and methods of manufacture and use.
DE10158039A1 (en) * 2001-11-27 2003-07-03 Kosmas Kg Anti-inflammatory agent and its use
CA2586035A1 (en) 2004-11-01 2006-05-11 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles in use for aesthetic or cosmetic medicine, and methods of manufacture and use
US20070190130A1 (en) * 2006-02-16 2007-08-16 Mark William A Protein hydrolysate excipients

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0326618A1 (en) * 1987-03-04 1989-08-09 Nippon Hypox Laboratories Incorporated Medicinal composition containing albumin as carrier and process for its preparation
CA1324083C (en) * 1987-03-09 1993-11-09 Tetsu Miyoshi Pharmaceutical preparations containing non-steroidal anti-inflammatory agents
JPH0288522A (en) * 1988-09-26 1990-03-28 Nippon Hai Potsukusu:Kk Non-steroidal anti-inflammatory agent composition and production thereof
JP2720079B2 (en) * 1989-09-18 1998-02-25 雪印乳業株式会社 Drugs containing acidic non-steroidal anti-inflammatory drugs
DE4225730C2 (en) * 1992-08-04 2003-04-30 Merz Pharma Gmbh & Co Kgaa Process for the preparation of solid dosage forms with protracted 2-stage release
DE4408326A1 (en) * 1994-03-11 1995-09-14 Hexal Pharma Gmbh Prolonged-release tablet containing diclofenac sodium
US5578576A (en) * 1994-09-02 1996-11-26 Dalhousie University Method and composition for treating intestinal wounds or ulcers
DE4444051A1 (en) * 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmaceutical, oral preparation

Also Published As

Publication number Publication date
WO1999003451A1 (en) 1999-01-28

Similar Documents

Publication Publication Date Title
AU7375598A (en) Stable oral pharmaceutical dosage forms
EP1001813B8 (en) Pharmaceutical formulations containing voriconazole
AU2638297A (en) Oral pharmaceutical preparation containing ibandronat
IL115097A0 (en) Pharmaceutical compositions adapted for oral administration
AU7572196A (en) Pharmaceutical formulations
AU1689999A (en) Medicinal composition for percutaneous administration
AU1827799A (en) Oral delivery formulation
IL145559A0 (en) Tolperison-containing pharmaceutical preparation for oral administration
AU5838398A (en) Rapamycin formulations for oral administration
AU6715600A (en) Pharmaceutical formulations
AU2564399A (en) Isoflavanoid formulations for oral administration
AU7420494A (en) Rapamycin formulations for oral administration
AU1354495A (en) Formulations for orally administered pharmaceutical agents
IL114673A (en) Pharmaceutical compositions containing protein for oral administration
HUP0003341A3 (en) Rapamycin formulations for oral administration
AU7735798A (en) Pharmaceutical composition for oral administration
AU4977300A (en) Pharmaceutical formulations
AU1385801A (en) Pharmaceutical formulations
AU3055099A (en) A pharmaceutical formulation for nasal administration
AU5347996A (en) Preparation for oral administration
AU3860797A (en) Pharmaceutical formulations for oral administration
AU2870899A (en) Oral formulation for hydrophilic drugs
AU1880599A (en) Pharmaceutical composition for oral administration
AU2896897A (en) Oral pharmaceutical compositions
AU5249500A (en) Medicinal composition for oral administration

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase